NanoViricides Inc
F:NV3P
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
NanoViricides Inc
F:NV3P
|
US |
|
T
|
Thai OPP PCL
SET:TOPP
|
TH |
|
R
|
Right Tunnelling PCL
SET:RT
|
TH |
|
Moncler SpA
OTC:MONRF
|
IT |
Intrinsic Value
Is NV3P undervalued or overvalued?
See the intrinsic value estimate for NanoViricides Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
NV3P looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with NV3P’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What NanoViricides Does
NanoViricides is a biotechnology company that tries to build antiviral drugs using a nanoparticle-based approach. Its core idea is to create drug candidates that can bind to viruses and block them from entering or infecting human cells. The company is still in the development stage, so it does not sell a broad line of commercial medicines; instead, it focuses on research, testing, and advancing drug candidates toward approval.
- Headquarters
- United States of America US
- Employees
- 17
- IPO date
- Aug 12, 2004
Revenue & Expenses Breakdown
NanoViricides Inc
Earnings Waterfall
NanoViricides Inc
The intrinsic value for NanoViricides Inc (NV3P) under the Base Case is hidden EUR.
Compared with the current market price of 1.08 EUR, the stock appears hidden.